Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Vanassche

Showing results (1-10 of 145) with videos related to

Pageof 15
Sort By:
Research and Practice in Thrombosis and Haemostasis|September 30, 2022
Acquired hemophilia following COVID-19 vaccination: Case report and review of literatureMichiel Happaerts, Thomas Vanassche
Advances in Therapy|June 29, 2013
Rivaroxaban for the treatment of pulmonary embolismThomas Vanassche, Peter Verhamme
Expert Review of Hematology|May 12, 2016
Reversal of dabigatran by idarucizumab: when and how?Thomas Vanassche, Andreas Greinacher, Peter Verhamme
Seminars in Thrombosis and Hemostasis|May 15, 2015
Coagulase Activity by Staphylococcus aureus: A Potential Target for Therapy?Marijke Peetermans, Peter Verhamme, Thomas Vanassche
Acta Cardiologica|May 16, 2022
The use of glucagon-like-peptide-1 receptor agonist in the cardiology practicePieter Martens, Chantal Mathieu, Thomas Vanassche
Acta Clinica Belgica|April 8, 2020
Tigecycline-induced life-threatening coagulopathy in a patient with a Mycobacterium abscess: a case report and step-by-step diagnostic approachSara Akalay, Thomas Vanassche, Paul De Munter
Seminars in Nephrology|January 17, 2024
Clotting of the Extracorporeal Circuit in Hemodialysis: Beyond Contact-Activated CoagulationMatthias M Engelen, Peter Verhamme, Thomas Vanassche
Journal of Thrombosis and Haemostasis : JTH|January 12, 2020
Coagulation: At the heart of infective endocarditisLaurens Liesenborghs, Severien Meyers, Thomas Vanassche, et al.
Expert Opinion on Pharmacotherapy|January 3, 2015
Pharmacotherapy with oral Xa inhibitors for venous thromboembolismThomas Vanassche, Christophe Vandenbriele, Kathelijne Peerlinck, et al.
European Heart Journal Supplements : Journal of the European Society of Cardiology|February 21, 2022
The value and limitations of new oral anticoagulant plasma level assessmentsLorenz Van der Linden, Julie Hias, Thomas Vanassche
Pageof 15

Showing results (1-10 of 145) with videos related to

Sort By:
Pageof 15
Research and Practice in Thrombosis and Haemostasis|September 30, 2022
Acquired hemophilia following COVID-19 vaccination: Case report and review of literatureMichiel Happaerts, Thomas Vanassche
Advances in Therapy|June 29, 2013
Rivaroxaban for the treatment of pulmonary embolismThomas Vanassche, Peter Verhamme
Expert Review of Hematology|May 12, 2016
Reversal of dabigatran by idarucizumab: when and how?Thomas Vanassche, Andreas Greinacher, Peter Verhamme
Seminars in Thrombosis and Hemostasis|May 15, 2015
Coagulase Activity by Staphylococcus aureus: A Potential Target for Therapy?Marijke Peetermans, Peter Verhamme, Thomas Vanassche
Acta Cardiologica|May 16, 2022
The use of glucagon-like-peptide-1 receptor agonist in the cardiology practicePieter Martens, Chantal Mathieu, Thomas Vanassche
Acta Clinica Belgica|April 8, 2020
Tigecycline-induced life-threatening coagulopathy in a patient with a Mycobacterium abscess: a case report and step-by-step diagnostic approachSara Akalay, Thomas Vanassche, Paul De Munter
Seminars in Nephrology|January 17, 2024
Clotting of the Extracorporeal Circuit in Hemodialysis: Beyond Contact-Activated CoagulationMatthias M Engelen, Peter Verhamme, Thomas Vanassche
Journal of Thrombosis and Haemostasis : JTH|January 12, 2020
Coagulation: At the heart of infective endocarditisLaurens Liesenborghs, Severien Meyers, Thomas Vanassche, et al.
Expert Opinion on Pharmacotherapy|January 3, 2015
Pharmacotherapy with oral Xa inhibitors for venous thromboembolismThomas Vanassche, Christophe Vandenbriele, Kathelijne Peerlinck, et al.
European Heart Journal Supplements : Journal of the European Society of Cardiology|February 21, 2022
The value and limitations of new oral anticoagulant plasma level assessmentsLorenz Van der Linden, Julie Hias, Thomas Vanassche
Pageof 15